| 04/30/2026 3:16 PM | Oncology Institute (1799191) Filer | Form DEF 14A | |
| 04/30/2026 3:18 PM | Oncology Institute (1799191) Filer | Form DEFA14A | |
| 04/28/2026 3:30 PM | Oncology Institute (1799191) Filer | Form ARS | |
| 04/23/2026 8:24 PM | Langsam Jeffrey (2069752) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/23/2026 8:25 PM | England Kristin (2078090) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/16/2026 6:27 PM | Kaushal Mohit (1683021) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/14/2026 3:35 PM | Kaushal Mohit (1683021) Reporting Oncology Institute (1799191) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/13/2026 8:03 AM | Chernett Jorey (2042077) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/01/2026 7:57 PM | England Kristin (2078090) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/01/2026 8:00 PM | Langsam Jeffrey (2069752) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/01/2026 7:46 PM | Oncology Institute (1799191) Issuer Virnich Daniel (1891107) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for TOIIW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Oncology Institute and its competitors with MarketBeat's FREE daily newsletter.
|
| 04/01/2026 7:47 PM | Carter Robert Ross (2039341) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/01/2026 7:51 PM | Oncology Institute (1799191) Issuer Podnos Yale (1891104) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/30/2026 8:38 AM | Chernett Jorey (2042077) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/27/2026 8:34 AM | Chernett Jorey (2042077) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/25/2026 8:33 AM | Chernett Jorey (2042077) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/23/2026 8:33 AM | Chernett Jorey (2042077) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/20/2026 3:34 PM | Oncology Institute (1799191) Issuer TZOUMAKAS KIMBERLY JO (1766666) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/17/2026 6:40 PM | Chernett Jorey (2042077) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/16/2026 7:30 AM | Chernett Jorey (2042077) Filed by Oncology Institute (1799191) Subject | Form SCHEDULE 13G/A | |
| 03/16/2026 7:32 AM | Chernett Jorey (2042077) Reporting Oncology Institute (1799191) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/13/2026 4:16 PM | Oncology Institute (1799191) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/12/2026 3:56 PM | Oncology Institute (1799191) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/23/2026 3:44 PM | Oncology Institute (1799191) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/15/2026 3:40 PM | Chernett Jorey (2042077) Filed by Oncology Institute (1799191) Subject | Form SCHEDULE 13G | |
| 01/12/2026 3:57 PM | Oncology Institute (1799191) Issuer STOLPER MARK (1281961) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 01/12/2026 7:00 AM | Oncology Institute (1799191) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/07/2026 4:02 PM | Oncology Institute (1799191) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/06/2026 3:30 PM | Carter Robert Ross (2039341) Reporting Oncology Institute (1799191) Issuer | Form 4/A | |
| 01/05/2026 4:04 PM | Carter Robert Ross (2039341) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/16/2025 3:30 PM | Hively Brad (1891124) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/15/2025 3:07 PM | Hively Brad (1891124) Reporting Oncology Institute (1799191) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/01/2025 3:45 PM | Ling Gabriel (1945281) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/24/2025 4:26 PM | McGeorge Anne (1779934) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/24/2025 4:20 PM | Hively Brad (1891124) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/24/2025 4:21 PM | Oncology Institute (1799191) Issuer Pacala Mark L (1321250) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/24/2025 4:21 PM | Johnson Karen Marie (1892819) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/24/2025 4:23 PM | Ling Gabriel (1945281) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/24/2025 4:25 PM | Kaushal Mohit (1683021) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/20/2025 3:55 PM | Oncology Institute (1799191) Issuer Pacala Mark L (1321250) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/20/2025 3:01 PM | M33 Growth I L.P. (1718621) Filed by Oncology Institute (1799191) Subject | Form SCHEDULE 13D/A | |
|
| 11/20/2025 3:02 PM | M33 Growth I GP LLC (1894303) Reporting M33 Growth I L.P. (1718621) Reporting Oncology Institute (1799191) Issuer TOI M, LLC (1892968) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/20/2025 3:02 PM | Ling Gabriel (1945281) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/19/2025 5:00 PM | Carter Robert Ross (2039341) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/19/2025 5:01 PM | Oncology Institute (1799191) Issuer Podnos Yale (1891104) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/19/2025 5:03 PM | Oncology Institute (1799191) Issuer Virnich Daniel (1891107) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/18/2025 3:05 PM | Oncology Institute (1799191) Subject Pacala Mark L (1321250) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/14/2025 5:18 AM | Oncology Institute (1799191) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/05/2025 5:12 AM | M33 Growth I GP LLC (1894303) Reporting M33 Growth I L.P. (1718621) Reporting Oncology Institute (1799191) Issuer TOI M, LLC (1892968) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/21/2025 2:13 PM | Hively Brad (1891124) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/14/2025 2:49 PM | BARASCH RICHARD A (1076341) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/13/2025 4:20 PM | Oncology Institute (1799191) Filer | Form 424B5 | |
| 08/13/2025 4:12 PM | Oncology Institute (1799191) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 07/28/2025 8:08 PM | BARASCH RICHARD A (1076341) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/24/2025 6:51 PM | England Kristin (2078090) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/22/2025 2:02 PM | England Kristin (2078090) Reporting Oncology Institute (1799191) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 06/24/2025 6:40 PM | FOG Ventures Investments, LLC (1895569) Filed by Oncology Institute (1799191) Subject | Form SCHEDULE 13G/A | |
| 06/24/2025 6:17 PM | BARASCH RICHARD A (1076341) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/20/2025 7:59 PM | BARASCH RICHARD A (1076341) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/19/2025 11:15 PM | Oncology Institute (1799191) Filer | Form EFFECT | |
| 06/16/2025 3:20 PM | Oncology Institute (1799191) Filer | Form S-3/A | |
| 06/05/2025 5:51 PM | Hively Brad (1891124) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/05/2025 5:13 PM | M33 Growth I L.P. (1718621) Reporting Oncology Institute (1799191) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/05/2025 5:17 PM | Oncology Institute (1799191) Subject TOI M, LLC (1892968) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/23/2025 12:02 PM | Langsam Jeffrey (2069752) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/23/2025 10:36 AM | Langsam Jeffrey (2069752) Reporting Oncology Institute (1799191) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 05/22/2025 6:38 PM | M33 Growth I GP LLC (1894303) Reporting M33 Growth I L.P. (1718621) Reporting Oncology Institute (1799191) Issuer TOI M, LLC (1892968) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/22/2025 1:12 PM | Carter Robert Ross (2039341) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/22/2025 1:17 PM | Oncology Institute (1799191) Issuer Podnos Yale (1891104) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/22/2025 1:22 PM | Oncology Institute (1799191) Issuer Virnich Daniel (1891107) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/22/2025 12:59 PM | Castle Jeremy (1992507) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/20/2025 5:25 PM | Oncology Institute (1799191) Subject TOI M, LLC (1892968) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/20/2025 5:19 PM | M33 Growth I L.P. (1718621) Reporting Oncology Institute (1799191) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/18/2025 11:15 PM | Oncology Institute (1799191) Filer | Form EFFECT | |
| 05/09/2025 1:57 PM | Oncology Institute (1799191) Filer | Form S-3 Registration statement under Securities Act of 1933 | |